IS INCREASED SERUM INTERLEUKIN-35 LEVELS A DISEASE ACTIVITY MARKER IN DERMATOMYOSITIS AND POLYMYOSITIS?

被引:0
|
作者
Yin, L. [1 ]
Wang, G. [2 ]
Ge, Y. [2 ]
机构
[1] Peking Univ, China Japan Friendship Sch Clin Med, Beijing, Peoples R China
[2] China Japan Friendship Hosp, Rheumatol, Beijing, Peoples R China
关键词
D O I
10.1136/annrheumdis-2016-eular.3606
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0615
引用
收藏
页码:1114 / 1114
页数:1
相关论文
共 50 条
  • [1] Interleukin-35: A Serological Biomarker for Patients with Polymyositis/Dermatomyositis
    Jiang, Qinglai
    Li, Yuxuan
    Xia, Liping
    Shen, Hui
    Lu, Jing
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (11): : 720 - 725
  • [2] Interleukin-35 Is Upregulated in Systemic Sclerosis and Its Serum Levels Are Increased in Early Disease
    Tomcik, Michal
    Zerr, Pawel
    Palumbo-Zerr, Katrin
    Storkanova, Hana
    Hulejova, Hana
    Spiritovic, Maja
    Kodet, Ondrej
    Stork, Jiri
    Becvar, Radim
    Vencovsky, Jiri
    Pavelka, Karel
    Filkova, Maria
    Distler, Jorg H. W.
    Senolt, Ladislav
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [3] Levels of cytokine inhibitors: A possible marker of disease activity in childhood dermatomyositis and polymyositis
    Prieur, AM
    Dayer, A
    RouxLombard, P
    Dayer, JM
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1997, 15 (02) : 211 - 214
  • [4] Evaluation of gingival crevicular fluid interleukin-35 as a marker for identification of periodontal disease activity
    Thakare, Kaustubh S.
    Charde, Priti A.
    Bhongade, Manohar L.
    Jaiswal, Priyanka P.
    Bajaj, Pavan S.
    MINERVA DENTAL AND ORAL SCIENCE, 2022, 71 (06) : 346 - 352
  • [5] Serum levels of interferon α do not correlate with disease activity in patients with dermatomyositis/polymyositis
    Krol, Petra
    Krystufkova, Olga
    Polanska, Marketa
    Mann, Herman
    Klein, Martin
    Beran, Ondrej
    Vencovsky, Jiri
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (05) : 879 - U318
  • [6] INTERLEUKIN-35 IS OVEREXPRESSED IN SYSTEMIC SCLEROSIS AND ITS SERUM LEVELS ARE ELEVATED IN EARLY DISEASE
    Tomcik, M.
    Zerr, P.
    Palumbo-Zerr, K.
    Storkanova, H.
    Hulejova, H.
    Spiritovic, M.
    Kodet, O.
    Stork, J.
    Becvar, R.
    Vencovsky, J.
    Pavelka, K.
    Filkova, M.
    Distler, J. H.
    Senolt, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 584 - 585
  • [7] Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
    Tomcik, Michal
    Zerr, Pawel
    Palumbo-Zerr, Katrin
    Storkanova, Hana
    Hulejova, Hana
    Spiritovic, Maja
    Kodet, Ondrej
    Stork, Jiri
    Becvar, Radim
    Vencovsky, Jiri
    Pavelka, Karel
    Filkova, Maria
    Distler, Joerg H. W.
    Senolt, Ladislav
    RHEUMATOLOGY, 2015, 54 (12) : 2273 - 2282
  • [8] Analysis of serum interleukin-10 and interleukin-35 levels In pemphigoid patients
    Kabuto, M.
    Fujimoto, N.
    Takahashi, T.
    Tanaka, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S91 - S91
  • [9] Elevated serum interleukin-35 is associated with disease activity in patients with systemic lupus erythematosus
    Li, Chun
    Liu, Na
    Zhu, Huaqun
    Xu, Liling
    Mu, Rong
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (12) : 2154 - 2156
  • [10] SERUM LEVELS OF IFN-α DO NOT CORRELATE WITH DISEASE ACTIVITY IN PATIENTS WITH DERMATOMYOSITIS/POLYMYOSITIS
    Vencovsky, J.
    Krol, P.
    Krystufkova, O.
    Polanska, P.
    Mann, H.
    Klein, M.
    Beran, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70